Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction

International Journal of Impotence Research volume 31, pages 223–230 (2019)Cite this article

Subjects

Abstract

Low intensity extracorporal shock wave therapy (Li-ESWT) may induce tissue regeneration, neo-angiogenesis and improve endothelial function. This has shown promise in the treatment of erectile dysfunction (ED). The aim of this narrative review was to describe potential therapeutic areas of Li-ESWT in sexual medicine other than ED. An extensive literature search and review of the most recent guidelines revealed that Li-ESWT has been used in the treatment of Peyronie’s disease (PD) and is being investigated as a method of improving stem cell therapy. In PD, Li-ESWT has been shown to decrease pain but no clinically relevant benefits regarding plaque size or penile curvature have been shown in randomized clinical trials. For stem cell optimization, only two preclinical studies have been conducted within the realm of sexual medicine. These show that application of Li-ESWT to the tissue after stem cell transplantation may increase the erectile response following cavernous nerve or diabetes damage. More research is needed to bring this concept from bench to bedside. In addition to this, Li-ESWT has shown promise in pelvic pain and it’s effects on testicles have been preliminarily investigated in preclinical studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Eisenberger F, Chaussy C. Contact-free renal stone fragmentation with shock waves. Urol Res. 1978;6:111.

    Article  CAS  PubMed  Google Scholar 

  2. Zhang L, Weng C, Zhao Z, Fu X. Extracorporeal shock wave therapy for chronic wounds: A systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen. 2017;25:697–706.

    Article  PubMed  Google Scholar 

  3. Ioppolo F, Rompe JD, Furia JP, Cacchio A. Clinical application of shock wave therapy (SWT) in musculoskeletal disorders. Eur J Phys Rehabil Med. 2014;50:217–30.

    CAS  PubMed  Google Scholar 

  4. Wang C-J, Wang F-S, Yang KD, Weng L-H, Hsu C-C, Huang C-S, et al. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res. 2003;21:984–9.

    Article  PubMed  Google Scholar 

  5. Chen Y-J, Wurtz T, Wang C-J, Kuo Y-R, Yang KD, Huang H-C, et al. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res. 2004;22:526–34.

    Article  CAS  PubMed  Google Scholar 

  6. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110:3055–61.

    Article  PubMed  Google Scholar 

  7. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006;114:2823–30.

    Article  PubMed  Google Scholar 

  8. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy–a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012;9:259–64.

    Article  PubMed  Google Scholar 

  9. Fischer S, Mueller W, Schulte M, Kiefer J, Hirche C, Heimer S, et al. Multiple extracorporeal shock wave therapy degrades capsular fibrosis after insertion of silicone implants. Ultrasound Med Biol. 2015;41:781–9.

    Article  PubMed  Google Scholar 

  10. Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med. 2017;14:1463–91.

    Article  PubMed  Google Scholar 

  11. Hatzimouratidis, K, Giuliano, F, Moncada, I, Muneer, A, Salonia, A, and Verze P. Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism. Eur. Assoc. Urol. Guidel. 2018.

  12. Fode M, Lowenstein L, Reisman Y. Low-Intensity Extracorporeal Shockwave Therapy in Sexual Medicine: A Questionnaire-Based Assessment of Knowledge, Clinical Practice Patterns, and Attitudes in Sexual Medicine Practitioners. Sex Med 2017;5. https://doi.org/10.1016/j.esxm.2016.12.002.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Gelbard MK, Dorey F, James K. The natural history of Peyronie’s disease. J Urol. 1990;144:1376–9.

    Article  CAS  PubMed  Google Scholar 

  14. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie’s disease. J Urol. 2002;168:1075–9.

    Article  PubMed  Google Scholar 

  15. Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie’s disease. J Urol. 2006;175:2115–8. discussion 2118

    Article  PubMed  Google Scholar 

  16. Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D. The natural history of Peyronie’s disease: an ultrasonography-based study. Eur Urol. 2008;53:644–50.

    Article  PubMed  Google Scholar 

  17. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350–3.

    Article  PubMed  Google Scholar 

  18. Levine LA, Burnett AL. Standard operating procedures for Peyronie’s disease. J Sex Med. 2013;10:230–44.

    Article  PubMed  Google Scholar 

  19. Gur S, Limin M, Hellstrom WJG. Current status and new developments in Peyronie’s disease: medical, minimally invasive and surgical treatment options. Expert Opin Pharmacother. 2011;12:931–44.

    Article  PubMed  Google Scholar 

  20. Bellorofonte C, Ruoppolo M, Tura M, Zaatar C, Tombolini P, Menchini Fabris GF. [Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis]. Arch Ital Urol Nefrol Androl. 1989;61:417–22.

    CAS  PubMed  Google Scholar 

  21. Abdel-Salam Y, Budair Z, Renner C, Frede T, Rassweiler J, El-Annany F, et al. Treatment of Peyronie’s disease by extracorporeal shockwave therapy: evaluation of our preliminary results. J Endourol. 1999;13:549–52.

    Article  CAS  PubMed  Google Scholar 

  22. Mirone V, Imbimbo C, Palmieri A, Fusco F. Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol. 1999;36:327–30.

    Article  CAS  PubMed  Google Scholar 

  23. Hauck EW, Altinkilic BM, Ludwig M, Ludecke G, Schroeder-Printzen I, Arens C, et al. Extracorporal shock wave therapy in the treatment of Peyronie’s disease. First results of a case-controlled approach. Eur Urol. 2000;38:663–9. discussion 670

    Article  CAS  PubMed  Google Scholar 

  24. Husain J, Lynn NN, Jones DK, Collins GN, O’Reilly PH. Extracorporeal shock wave therapy in the management of Peyronie’s disease: initial experience. BJU Int. 2000;86:466–8.

    Article  CAS  PubMed  Google Scholar 

  25. Lebret T, Loison G, Herve J-M, Mc Eleny KR, Lugagne P-M, Yonneau L, et al. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: experience with standard lithotriptor (siemens-multiline). Urology. 2002;59:657–61.

    Article  PubMed  Google Scholar 

  26. Claro JA, Passerotti CC, Figueiredo Neto AC, Nardozza AJ, Ortiz V, Srougi M. An alternative non-invasive treatment for Peyronie’s disease. Int Braz J Urol. 2004;30:199–204. discussion 204

    Article  PubMed  Google Scholar 

  27. Skolarikos A, Alargof E, Rigas A, Deliveliotis C, Konstantinidis E. Shockwave therapy as first-line treatment for Peyronie’s disease: a prospective study. J Endourol. 2005;19:11–4.

    Article  CAS  PubMed  Google Scholar 

  28. Srirangam SJ, Manikandan R, Hussain J, Collins GN, O’Reilly PH. Long-term results of extracorporeal shockwave therapy for Peyronie’s disease. J Endourol. 2006;20:880–4.

    Article  PubMed  Google Scholar 

  29. Poulakis V, Skriapas K, de Vries R, Dillenburg W, Ferakis N, Witzsch U, et al. Extracorporeal shockwave therapy for Peyronie’s disease: an alternative treatment? Asian J Androl. 2006;8:361–6.

    Article  PubMed  Google Scholar 

  30. Chung E. Peyronie’s disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men. Korean J Urol. 2015;56:775–80.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Strebel RT, Suter S, Sautter T, Hauri D. Extracorporeal shockwave therapy for Peyronie’s disease does not correct penile deformity. Int J Impot Res. 2004;16:448–51.

    Article  CAS  PubMed  Google Scholar 

  32. Michel MS, Ptaschnyk T, Musial A, Braun P, Lenz ST, Alken P, et al. Objective and subjective changes in patients with Peyronie’s disease after management with shockwave therapy. J Endourol. 2003;17:41–4. discussion 44

    Article  PubMed  Google Scholar 

  33. Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, et al. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol. 2009;56:363–9.

    Article  PubMed  Google Scholar 

  34. Chitale S, Morsey M, Swift L, Sethia K. Limited shock wave therapy vs sham treatment in men with Peyronie’s disease: results of a prospective randomized controlled double-blind trial. BJU Int. 2010;106:1352–6.

    Article  PubMed  Google Scholar 

  35. Hatzichristodoulou G, Meisner C, Gschwend JE, Stenzl A, Lahme S. Extracorporeal shock wave therapy in Peyronie’s disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med. 2013;10:2815–21.

    Article  PubMed  Google Scholar 

  36. Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl. 2012;35:190–5.

    Article  CAS  PubMed  Google Scholar 

  37. Gao L, Qian S, Tang Z, Li J, Yuan J. A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease. Int J Impot Res. 2016;28:161–6.

    Article  CAS  PubMed  Google Scholar 

  38. Fode M, Hatzichristodoulou G, Serefoglu EC, Verze P, Albersen M. Low-intensity shockwave therapy for erectile dysfunction: Is the evidence strong enough? Nat Rev Urol. 2017;14. https://doi.org/10.1038/nrurol.2017.119.

    Article  CAS  PubMed  Google Scholar 

  39. Assaly-Kaddoum R, Giuliano F, Laurin M, Gorny D, Kergoat M, Bernabe J, et al. Low Intensity Extracorporeal Shock Wave Therapy Improves Erectile Function in a Model of Type II Diabetes Independently of NO/cGMP Pathway. J Urol. 2016;196:950–6.

    Article  PubMed  Google Scholar 

  40. Qiu X, Lin G, Xin Z, Ferretti L, Zhang H, Lue TF, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013;10:738–46.

    Article  CAS  PubMed  Google Scholar 

  41. Liu J, Zhou F, Li G-Y, Wang L, Li H-X, Bai G-Y, et al. Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats. Int J Mol Sci. 2013;14:10661–73.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lei H, Xin H, Guan R, Xu Y, Li H, Tian W, et al. Low-intensity Pulsed Ultrasound Improves Erectile Function in Streptozotocin-induced Type I Diabetic Rats. Urology. 2015;86:1241.e11–8.

    Article  Google Scholar 

  43. Seemann O, Rassweiler J, Chvapil M, Alken P, Drach GW. The effect of single shock waves on the vascular system of artificially perfused rabbit kidneys. J Stone Dis. 1993;5:172–8.

    CAS  PubMed  Google Scholar 

  44. Andrade E, Cortez I, Claro J, Pompeu E, Leite K, Paranhos M, et al. Preliminary findings from a new animal model for Peyronie’s disease involving extracorporeal shock waves. BJU Int. 2009;103:1104–6.

    Article  PubMed  Google Scholar 

  45. Al-Thakafi S, Al-Hathal N. Peyronie’s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol. 2016;5:280–9.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Frairia R, Berta L. Biological effects of extracorporeal shock waves on fibroblasts. A review. Muscles Ligaments Tendons J. 2011;1:138–47.

    PubMed  Google Scholar 

  47. Mulhall JP, Rajfer J. Advances in sexual medicine: highlights from the 2007 winter meeting of the sexual medicine society of north america, december 6-9, 2007, chicago, IL. Rev Urol. 2008;10:232–5.

    PubMed  PubMed Central  Google Scholar 

  48. Soebadi MA, Milenkovic U, Weyne E, Castiglione F, Albersen M. Stem Cells in Male Sexual Dysfunction: Are We Getting Somewhere? Sex Med Rev. 2017;5:222–35.

    Article  PubMed  Google Scholar 

  49. Raabe O, Shell K, Goessl A, Crispens C, Delhasse Y, Eva A, et al. Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells. 2013;2:62–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Priglinger E, Schuh CMAP, Steffenhagen C, Wurzer C, Maier J, Nuernberger S, et al. Improvement of adipose tissue-derived cells by low-energy extracorporeal shock wave therapy. Cytotherapy. 2017;19:1079–95.

    Article  CAS  PubMed  Google Scholar 

  51. Zhang H, Li Z-L, Yang F, Zhang Q, Su X-Z, Li J, et al. Radial shockwave treatment promotes human mesenchymal stem cell self-renewal and enhances cartilage healing. Stem Cell Res Ther. 2018;9:54.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wang F-S, Yang KD, Wang C-J, Huang H-C, Chio C-C, Hsu T-Y, et al. Shockwave stimulates oxygen radical-mediated osteogenesis of the mesenchymal cells from human umbilical cord blood. J Bone Miner Res. 2004;19:973–82.

    Article  CAS  PubMed  Google Scholar 

  53. Yip H-K, Chang L-T, Sun C-K, Youssef AA, Sheu J-J, Wang C-J. Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J. 2008;72:150–6.

    Article  CAS  PubMed  Google Scholar 

  54. Hu J, Liao H, Ma Z, Chen H, Huang Z, Zhang Y, et al. Focal Adhesion Kinase Signaling Mediated the Enhancement of Osteogenesis of Human Mesenchymal Stem Cells Induced by Extracorporeal Shockwave. Sci Rep. 2016;6:20875.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Sun D, Junger WG, Yuan C, Zhang W, Bao Y, Qin D, et al. Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors. Stem Cells. 2013;31:1170–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Leone L, Raffa S, Vetrano M, Ranieri D, Malisan F, Scrofani C, et al. Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs). Oncotarget. 2016;7:6410–23.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Wang B, Zhou J, Banie L, Reed-Maldonado AB, Ning H, Lu Z, et al. Low-intensity extracorporeal shock wave therapy promotes myogenesis through PERK/ATF4 pathway. Neurourol Urodyn. 2018;37:699–707.

    Article  CAS  PubMed  Google Scholar 

  58. Yeh K-H, Sheu J-J, Lin Y-C, Sun C-K, Chang L-T, Kao Y-H, et al. Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats. Crit Care Med. 2012;40:169–77.

    Article  PubMed  Google Scholar 

  59. Yin T-C, Wu R-W, Sheu J-J, Sung P-H, Chen K-H, Chiang JY, et al. Combined Therapy with Extracorporeal Shock Wave and Adipose-Derived Mesenchymal Stem Cells Remarkably Improved Acute Ischemia-Reperfusion Injury of Quadriceps Muscle. Oxid Med Cell Longev. 2018;2018:6012636.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Zhai L, Ma X-L, Jiang C, Zhang B, Liu S-T, Xing G-Y. Human autologous mesenchymal stem cells with extracorporeal shock wave therapy for nonunion of long bones. Indian J Orthop. 2016;50:543–50.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Jeon SH, Shrestha KR, Kim RY, Jung AR, Park YH, Kwon O, et al. Combination Therapy Using Human Adipose-derived Stem Cells on the Cavernous Nerve and Low-energy Shockwaves on the Corpus Cavernosum in a Rat Model of Post-prostatectomy Erectile Dysfunction. Urology. 2016;88:226.e1–9.

    Article  Google Scholar 

  62. Shan H-T, Zhang H-B, Chen W-T, Chen F-Z, Wang T, Luo J-T, et al. Combination of low-energy shock-wave therapy and bone marrow mesenchymal stem cell transplantation to improve the erectile function of diabetic rats. Asian J Androl. 2017;19:26–33.

    CAS  PubMed  Google Scholar 

  63. Capogrosso P, Montorsi F, Salonia A. Phase I and phase II clinical trials for the treatment of male sexual dysfunction-a systematic review of the literature. Expert Opin Investig Drugs. 2018;27:583–93.

    Article  CAS  PubMed  Google Scholar 

  64. Fode M, Ohl DA, Ralph D, Sønksen J. Penile rehabilitation after radical prostatectomy: What the evidence really says. BJU Int. 2013;112. https://doi.org/10.1111/bju.12228.

  65. Zimmermann R, Cumpanas A, Hoeltl L, Janetschek G, Stenzl A, Miclea F. Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results. BJU Int. 2008;102:976–80.

    Article  PubMed  Google Scholar 

  66. Zimmermann R, Cumpanas A, Miclea F, Janetschek G. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol. 2009;56:418–24.

    Article  PubMed  Google Scholar 

  67. Zeng X-Y, Liang C, Ye Z-Q. Extracorporeal shock wave treatment for non-inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham-controlled study. Chin Med J (Engl). 2012;125:114–8.

    Google Scholar 

  68. Pajovic B, Radojevic N, Dimitrovski A, Vukovic M. Comparison of the efficiency of combined extracorporeal shock-wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). aging male Off J Int Soc Study Aging Male. 2016;19:202–7.

    Article  CAS  Google Scholar 

  69. Guu S-J, Geng J-H, Chao I-T, Lin H-T, Lee Y-C, Juan Y-S, et al. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy on Men With Chronic Pelvic Pain Syndrome Refractory to 3-As Therapy. Am J Mens Health. 2018;12:441–52.

    Article  PubMed  Google Scholar 

  70. Al Edwan GM, Muheilan MM, Atta ONM. Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis. Ann Med Surg. 2017;14:12–7.

    Article  Google Scholar 

  71. Basar MM, Samli MM, Erbil M, Ozergin O, Basar R, Atan A. Early effects of extracorporeal shock-wave lithotripsy exposure on testicular sperm morphology. Scand J Urol Nephrol. 2004;38:38–41.

    Article  PubMed  Google Scholar 

  72. Zang Z-J, Liu Q, Hu J, Feng J, Zhu Y-Q, Ma G et al. The impact of low-intensity extracorporeal shock wave therapy on testicular function in adult rats. Andrology. 2018. https://doi.org/10.1111/andr.12534.

    Article  PubMed  Google Scholar 

  73. Yu G, Guan Y, Liu L, Xing J, Li J, Cheng Q, et al. The protective effect of low-energy shock wave on testicular ischemia-reperfusion injury is mediated by the PI3K/AKT/NRF2 pathway. Life Sci. 2018;213:142–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Herlev and Gentofte Hospital, Gentofte, Denmark

    Mikkel Fode

  2. Urology Section, Department of Surgery, University of Catania, Catania, Italy

    Giorgio I. Russo

  3. Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy

    Paolo Verze

Authors
  1. Mikkel Fode
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giorgio I. Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo Verze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mikkel Fode.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fode, M., Russo, G.I. & Verze, P. Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction. Int J Impot Res 31, 223–230 (2019). https://doi.org/10.1038/s41443-019-0114-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-019-0114-2

This article is cited by

Search

Advanced search

Quick links